|
Market Closed -
Australian S.E.
10:40:10 19/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.035 AUD | -6.76% |
|
+1.47% | +146.43% |
| Market Cap | 24Cr 17Cr 15Cr 14Cr 12Cr 23Cr 1.57TCr 164.25Cr 64Cr 821.41Cr 62Cr 61Cr 2.62TCr | P/E 2025 |
17.8x | P/E 2026 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 23Cr 16Cr 14Cr 13Cr 12Cr 23Cr 1.54TCr 160.91Cr 63Cr 804.68Cr 61Cr 60Cr 2.57TCr | EV / Sales 2025 |
2.82x | EV / Sales 2026 | 2.82x |
| Free-Float |
41.81% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| BLS | Delayed | |
Deutsche Boerse AG
| PR80 | Delayed | |
|
Boerse Muenchen
| PR80 | Real-time |
Last Transcript: BLS Pharmaceuticals Limited
| 1 day | -6.76% | ||
| 1 week | +1.47% | ||
| Current month | -1.43% | ||
| 1 month | -19.77% | ||
| 3 months | +19.65% | ||
| 6 months | +50.00% | ||
| Current year | +146.43% |
| 1 week | 1.02 |  | 1.13 |
| 1 month | 0.94 | | 1.27 |
| Current year | 0.36 | | 1.3 |
| 1 year | 0.35 | | 1.3 |
| 3 years | 0.04 | | 1.3 |
| 5 years | 0.04 | | 1.3 |
| 10 years | 0.04 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 19/05/2023 |
Guy Robertson
DFI | Director of Finance/CFO | 72 | 01/09/2016 |
Jason Hine
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Ho
CHM | Chairman | 67 | 05/12/2012 |
Guy Robertson
BRD | Director/Board Member | 72 | 30/06/2022 |
Sam Watson
BRD | Director/Board Member | - | 19/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/05/26 | Buy | 50,00,000 | 0.2202% | |||
| 14/05/26 | Exercice | 50,00,000 | 0.2202% | |||
| 22/03/26 | Buy | Chief Executive Officer | 18,00,000 | 0.0804% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.76% | +1.47% | +165.38% | +840.91% | 18Cr | |
| -0.93% | +6.08% | +55.07% | +112.34% | 1,12000Cr | |
| -1.43% | -4.15% | +30.49% | +65.95% | 62TCr | |
| -0.39% | +1.47% | +22.92% | +96.01% | 50TCr | |
| -0.11% | +5.58% | +35.22% | +59.40% | 37TCr | |
| -0.43% | +0.35% | +69.09% | +45.34% | 36TCr | |
| -0.60% | +3.47% | +19.19% | +46.45% | 29TCr | |
| -0.39% | +3.36% | -1.07% | +18.52% | 26TCr | |
| -0.66% | +3.32% | +42.23% | +53.76% | 23TCr | |
| -0.65% | +3.87% | +26.92% | +99.20% | 19TCr | |
| Average | -1.24% | +3.86% | +46.54% | +143.79% | 39.41TCr | |
| Weighted average by Cap. | -0.73% | +3.52% | +38.12% | +76.91% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 2.93Cr 2.04Cr 1.81Cr 1.68Cr 1.53Cr 2.88Cr 193.36Cr 20Cr 7.91Cr 100.9Cr 7.65Cr 7.48Cr 321.66Cr | 7.39Cr 5.14Cr 4.57Cr 4.24Cr 3.85Cr 7.27Cr 488.07Cr 51Cr 20Cr 254.7Cr 19Cr 19Cr 811.93Cr |
| Net income | 49.01L 34.1L 30.31L 28.1L 25.56L 48.24L 32Cr 3.38Cr 1.32Cr 17Cr 1.28Cr 1.25Cr 54Cr | 1.54Cr 1.07Cr 95.23L 88.26L 80.31L 1.52Cr 101.68Cr 11Cr 4.16Cr 53Cr 4.02Cr 3.94Cr 169.14Cr |
| Net Debt | -61.34L -42.68L -37.94L -35.16L -31.99L -60.37L -41Cr -4.23Cr -1.66Cr -21Cr -1.6Cr -1.57Cr -67Cr | -48.56L -33.79L -30.03L -27.84L -25.33L -47.79L -32Cr -3.35Cr -1.31Cr -17Cr -1.27Cr -1.24Cr -53Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | A$1.035 | -6.76% | 5,35,084 |
| 16/26/16 | A$1.110 | +2.30% | 2,48,383 |
| 15/26/15 | A$1.085 | 0.00% | 5,92,164 |
| 14/26/14 | A$1.085 | +4.33% | 4,16,857 |
| 13/26/13 | A$1.040 | +2.46% | 1,93,438 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BLS Stock
Select your edition
All financial news and data tailored to specific country editions
